BioXcel Therapeutics Inc. (BTAI)
1.83
0.19 (11.59%)
At close: Apr 11, 2025, 3:59 PM
1.76
-3.77%
After-hours: Apr 11, 2025, 05:39 PM EDT
13F Institute Ownership
Total Institutes of 48 in BioXcel Therapeutics reduced their positions with a decrease of 2 investors compared to the previous quarter. An additional 5.47M shares, as total invested capital grew by $1.31M with ownership percentage increasing from 0.46% to 1.26%.
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 1.722
1.72
Call Flow 34,500
37%
Put Flow 59,400
63%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 10.18% | 4.32M | +100.00% | 1.61M | 0.02% |
| Ubs Group Ag | 3.01% | 1.28M | +9.55K% | 477.56K | < 0.01% |
| Vanguard Group Inc | 2.80% | 1.19M | -1.16% | 444.11K | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.